“Response to treatment of cutaneous leishmaniasis with intralesional chloroquine vs intralesional meglumine antimoniate”, J Pak Assoc Dermatol, vol. 21, no. 4, pp. 270–275, Dec. 2016, doi: 10.66344/jpad.v21i4.488.